BRI2-mediated regulation of TREM2 processing in microglia and its potential implications for Alzheimer’s disease and related dementias
暂无分享,去创建一个
[1] Young-Eun Kim,et al. A Novel c.800G>C Variant of the ITM2B Gene in Familial Korean Dementia. , 2023, Journal of Alzheimer's disease : JAD.
[2] S. Lichtenthaler,et al. Secretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2 , 2021, Current Opinion in Neurobiology.
[3] M. Colonna,et al. Microglia in Alzheimer's disease at single-cell level. Are there common patterns in humans and mice? , 2021, The Journal of experimental medicine.
[4] Q. Dong,et al. A Novel ITM2B Mutation Associated with Familial Chinese Dementia. , 2021, Journal of Alzheimer's disease : JAD.
[5] L. D’Adamio,et al. Danish and British dementia ITM2b/BRI2 mutations reduce BRI2 protein stability and impair glutamatergic synaptic transmission , 2020, The Journal of biological chemistry.
[6] Raphael Gottardo,et al. Integrated analysis of multimodal single-cell data , 2020, Cell.
[7] M. Tambini,et al. Trem2 Splicing and Expression are Preserved in a Human Aβ-producing, Rat Knock-in Model of Trem2-R47H Alzheimer’s Risk Variant , 2020, Scientific Reports.
[8] A. Fisahn,et al. Augmentation of Bri2 molecular chaperone activity against amyloid-β reduces neurotoxicity in mouse hippocampus in vitro , 2020, Communications Biology.
[9] C. Betsholtz,et al. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines , 2019, Transgenic Research.
[10] Yvan Saeys,et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment , 2019, Nature Neuroscience.
[11] M. Tambini,et al. The Familial dementia gene ITM2b/BRI2 facilitates glutamate transmission via both presynaptic and postsynaptic mechanisms , 2019, Scientific Reports.
[12] J. Trojanowski,et al. Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology , 2019, Molecular Neurodegeneration.
[13] Stephan J Sanders,et al. Integrative functional genomic analysis of human brain development and neuropsychiatric risks , 2018, Science.
[14] Fan Zhang,et al. Fast, sensitive, and accurate integration of single cell data with Harmony , 2018, bioRxiv.
[15] Lars E. Borm,et al. Molecular Architecture of the Mouse Nervous System , 2018, Cell.
[16] D. Holtzman,et al. High affinity interactions and signal transduction between Aβ oligomers and TREM2 , 2018, bioRxiv.
[17] Leland McInnes,et al. UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction , 2018, ArXiv.
[18] P. S. St George-Hyslop,et al. TREM2 shedding by cleavage at the H157‐S158 bond is accelerated for the Alzheimer's disease‐associated H157Y variant , 2017, EMBO molecular medicine.
[19] J. Johansson,et al. BRICHOS – an anti-amyloid chaperone: evaluation of blood-brain barrier permeability of Bri2 BRICHOS , 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[20] Lino C. Gonzalez,et al. TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia , 2016, Neuron.
[21] K. Blennow,et al. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease , 2016, Molecular Neurodegeneration.
[22] A. Fagan,et al. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status , 2016, Acta Neuropathologica.
[23] J. Molinuevo,et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.
[24] H. Neumann,et al. Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage* , 2013, The Journal of Biological Chemistry.
[25] A. Mildner,et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. , 2013, Immunity.
[26] A. Singleton,et al. TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.
[27] L. D’Adamio,et al. Inhibition of γ-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia , 2012, Molecular Neurodegeneration.
[28] L. D’Adamio,et al. Memory Deficits of British Dementia Knock-In Mice Are Prevented by Aβ-Precursor Protein Haploinsufficiency , 2012, The Journal of Neuroscience.
[29] O. Arancio,et al. β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia , 2012, Molecular Neurodegeneration.
[30] E. Snapp,et al. Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles , 2011, Neurobiology of Aging.
[31] O. Arancio,et al. APP heterozygosity averts memory deficit in knockin mice expressing the Danish dementia BRI2 mutant , 2011, The EMBO journal.
[32] O. Arancio,et al. Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficits , 2010, Proceedings of the National Academy of Sciences.
[33] Wei Li,et al. Memory Deficits Due to Familial British Dementia BRI2 Mutation Are Caused by Loss of BRI2 Function Rather than Amyloidosis , 2010, The Journal of Neuroscience.
[34] B. Ghetti,et al. Modeling familial British and Danish dementia , 2010, Brain Structure and Function.
[35] E. McGowan,et al. BRI2 Inhibits Amyloid β-Peptide Precursor Protein Processing by Interfering with the Docking of Secretases to the Substrate , 2008, The Journal of Neuroscience.
[36] E. Levy,et al. Axonal transport of British and Danish amyloid peptides via secretory vesicles , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] P. Vito,et al. Autosomal Recessive Hypercholesterolemia Protein Interacts with and Regulates the Cell Surface Level of Alzheimer's Amyloid β Precursor Protein* , 2003, Journal of Biological Chemistry.
[38] K. Blennow,et al. Intrathecal inflammation precedes development of Alzheimer’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.
[39] J. Sutcliffe,et al. Heterogeneous expression of the triggering receptor expressed on myeloid cells‐2 on adult murine microglia , 2002, Journal of neurochemistry.
[40] R. Roncarati,et al. Jun NH2-terminal Kinase (JNK) Interacting Protein 1 (JIP1) Binds the Cytoplasmic Domain of the Alzheimer's β-Amyloid Precursor Protein (APP)* , 2002, The Journal of Biological Chemistry.
[41] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[42] T Bek,et al. A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[43] Agueda Rostagno,et al. A stop-codon mutation in the BRI gene associated with familial British dementia , 1999, Nature.
[44] L. D’Adamio,et al. Increased AβPP processing in familial Danish dementia patients. , 2011, Journal of Alzheimer's disease : JAD.
[45] P. Davies,et al. The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production. , 2005, The Journal of biological chemistry.